Laboratory Question for the Week of June 8, 2026
Under PAMA regulations, how is pricing determined for new laboratory test codes that do not yet have established Medicare payment rates?
Under PAMA regulations, how is pricing determined for new laboratory test codes that do not yet have established Medicare payment rates?
What distinguishes a Type 2 MI from a Type 1 MI, and how does it typically present on ECG?
When an attempted lower extremity intervention is unsuccessful, should only the catheterization and diagnostic angiography be coded, or can the attempted intervention also be reported?
Can we use the time in and out of the department to calculate billable units of service for respiratory rehabilitation service codes?
When is CPT® add-on code +0993T reported for augmentative software analysis performed with a CT scan of the heart? Case Example: A patient with multiple cardiovascular risk factors, including obesity, hypertension, a history of smoking, and elevated inflammatory markers, underwent coronary CT angiography (CCTA) for evaluation of coronary artery disease. The patient was placed supine in the CT scanner, and a gated coronary CT angiography study was performed using standard institutional protocol with intravenous contrast. Image quality was confirmed adequate for diagnostic review. Immediately following image acquisition, the CCTA dataset was transferred to an AI-powered perivascular fat analysis platform. The software automatically identified the coronary arteries, extracted perivascular fat regions, and calculated vessel-specific fat attenuation index (FAI) measurements associated with coronary vascular inflammation. Clinical risk factors, including body mass index (BMI), smoking history, high-sensitivity C-reactive protein (hs-CRP), and blood pressure, were incorporated into the software analysis to refine the inflammation-based risk assessment. The platform generated a comprehensive cardiac inflammation profile that integrated coronary plaque characteristics with biologic inflammatory markers. The interpreting cardiologist reviewed both the primary CCTA findings and the AI-generated FAI metrics. The combined report concluded: (1) no obstructive coronary artery disease, (2) mixed noncalcified plaque within the proximal left anterior descending (LAD) artery, and (3) elevated FAI values indicating increased vascular inflammatory activity. Based on these findings, therapy intensification was recommended.
What changes did CMS finalize regarding pulmonary rehabilitation coverage and requirements?
How is blood flow maintained to the brachiocephalic vessels when a thoracic endograft would otherwise cover the innominate, left common carotid, or left subclavian arteries?
What is the correct coding for the initial hour of hydration therapy, and how is the unit of service reported?
What does an MUE (Medically Unlikely Edit) represent in relation to HCPCS/CPT® coding?
Have HCPCS codes C9600–C9608 changed for 2026?
How could the proposed efficiency adjustment and facility PE reductions impact reimbursement for cardiology services, and what strategies can practices use to offset potential revenue declines?
What types of improper laboratory claims are targeted in potential future OIG and Medicare audits?
CPT® copyright 2025 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24